Drug Profile
Ordopidine
Alternative Names: ACR-325Latest Information Update: 28 Jun 2019
Price :
$50
*
At a glance
- Originator Carlsson Research AB; NeuroSearch Sweden AB
- Developer Saniona
- Class Antidepressants; Antimanics; Fluorobenzenes; Piperidines; Sulfones
- Mechanism of Action Adrenergic receptor modulators; Dopamine release modulators; Glutamate agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bipolar disorders; Parkinson's disease
Most Recent Events
- 28 Jun 2019 No recent reports of development identified for phase-I development in Bipolar-disorders in Sweden (PO)
- 28 Jun 2019 No recent reports of development identified for phase-I development in Parkinson's-disease in Germany (PO)
- 28 Jun 2019 No recent reports of development identified for phase-I development in Parkinson's-disease in Sweden (PO)